Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming
SAN FRANCISCO, Jan. 19, 2022 /PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep b...
Stay updated with breaking news from Altos Institutes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN FRANCISCO, Jan. 19, 2022 /PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep b...
Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation...
/PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation...
With $3 billion in capital and an executive team to be led by Hal Barron, MD, until now GlaxoSmithKline (GSK)’s President of R&D and Chief Scientific Officer, Altos Labs™ today emerged from stealth mode, launching as an anti-aging startup with the ambitious aim of reversing disease, injury, and disabilities through cellular rejuvenation programming.